Results 211 to 220 of about 113,465 (266)

Genetic Characterization of First-Line Drug-Resistance Mutations in Multidrug-Resistant <i>Mycobacterium tuberculosis</i>. [PDF]

open access: yesPathogens
Gul M   +11 more
europepmc   +1 more source

Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective study. [PDF]

open access: yesLancet Microbe
Steyn J   +14 more
europepmc   +1 more source

Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistant Mycobacterium tuberculosis through Efflux

open access: yesAmerican Journal of Respiratory and Critical Care Medicine, 2011
Rationale: Central dogma suggests that rifampicin resistance in Mycobacterium tuberculosis develops solely through rpoB gene mutations. Objective: To determine whether rifampicin induces efflux pumps activation in rifampicin resistant M.
Nicolaas C Gey Van Pittius   +2 more
exaly   +2 more sources

Rifampicin quinone is an immunosuppressant, but not rifampicin itself

Clinical Immunology and Immunopathology, 1988
Rifampicin as a potential immunosuppressive agent was tested in the rat. A freshly made-up solution of this labile antibiotic in a daily dosage of 20 mg/kg iv did not affect mean graft survival time in a heterotopic heart transplant model. However, when stored solutions of rifampicin were used mean graft survival time was significantly prolonged (from ...
P, Konrad, P, Stenberg
openaire   +2 more sources

RIFAMPICIN

The Lancet, 1969
J M, Murdoch   +3 more
openaire   +4 more sources

RIFAMPICIN AND THE LIVER

The Lancet, 1978
G, Acocella, A, Luvará, M, Guaglianone
openaire   +2 more sources

RIFAMPICIN: AN IMMUNOSUPPRESSANT ?

The Lancet, 1972
B M, Dajani   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy